Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Danaher Corp (DHR) Common Stock USD0.01

Sell:$138.43 Buy:$138.45 Change: $1.37 (1.00%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Change: $1.37 (1.00%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Change: $1.37 (1.00%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Contact details

2200 Pennsylvania Ave NW Ste 800w
United States
+1 (202) 8280850

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$99.16 billion
Shares in issue:
717.37 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Steven Rales
    Chairman of the Board
  • Matthew McGrew
    Chief Financial Officer, Executive Vice President
  • Rainer Blair
    Executive Vice President
  • Daniel Comas
    Executive Vice President
  • William Daniel
    Executive Vice President
  • Joakim Weidemanis
    Executive Vice President
  • Robert Lutz
    Senior Vice President, Chief Accounting Officer
  • Brian Ellis
    Senior Vice President, Chief Compliance Officer, General Counsel
  • Angela Lalor
    Senior Vice President - Human Resources
  • William King
    Senior Vice President - Strategic Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.